CD13/APN Transcription Is Induced by RAS/MAPK-mediated Phosphorylation of Ets-2 in Activated Endothelial Cells*

CD13/aminopeptidase N (CD13/APN) is a potent regulator of angiogenesis both in vitro and in vivo and transcription of CD13/APN in endothelial cells is induced by angiogenic growth factors via the RAS/MAPK pathway. We have explored the nuclear effectors downstream of this pathway that are responsible for CD13/APN induction. The response to serum/angiogenic growth factors mapped to a 38-bp region of the CD13/APN promoter containing an Ets-core motif that specifically binds a protein complex from nuclear lysates from activated endothelial cells. This motif and the proteins that target it are functionally relevant because mutation of this sequence abrogates CD13/APN transcription. Analysis of endothelial Ets family members showed that Ets-2, and to a lesser extent Ets-1, transactivate CD13/APN promoter activity via the Ets-core motif, whereas Fli, Erg, and NERF are ineffective. We investigated the possibility that the induction of CD13/APN is mediated by phosphorylation of Ets-2 via RAS/MAPK. A phosphorylation-defective Ets-2 mutant, T72A, failed to transactivate CD13/APN, suggesting that Ets-2 phosphorylation is obligatory for CD13/APN induction. To confirm a role for endogenous Ets-2 in CD13/APN expression, we specifically abrogated Ets-2 mRNA and protein by siRNA knockdown that significantly inhibited CD13/APN transcription. Finally, to assess the relevance of Ets-2 in endothelial cell function, we induced endothelial cells containing Ets-2 siRNA oligonucleotides to form capillary networks. Cells containing the Ets-2 inhibitory small interfering RNAs were completely incapable of forming the organized networks characteristic of endothelial morphogenesis. Thus, the phosphorylation of Ets-2 by RAS/MAPK is a prerequisite for CD13/APN endothelial induction and Ets-2 and its targets play essential roles in endothelial cell function.

[1]  Michael C. Ostrowski,et al.  A central role for Ets-2 in the transcriptional regulation and cyclic adenosine 5'-monophosphate responsiveness of the human chorionic gonadotropin-beta subunit gene. , 2003, Molecular endocrinology.

[2]  David Baunoch,et al.  Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT , 1997, Nature.

[3]  L. Shapiro,et al.  The angiogenic regulator CD13/APN is a transcriptional target of Ras signaling pathways in endothelial morphogenesis. , 2003, Blood.

[4]  S. McKnight,et al.  Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. , 1997, Genes & development.

[5]  K. Ballingall,et al.  The DY sub-region of the sheep MHC contains an A/B gene pair , 2004, Immunogenetics.

[6]  R Pasqualini,et al.  Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis. , 2000, Cancer research.

[7]  A. Kehlen,et al.  CD13—not just a marker in leukemia typing , 1999, Immunology Today.

[8]  F. Palmieri,et al.  Metabolism of vasoactive peptides by vascular endothelium and smooth muscle aminopeptidase M. , 1989, Biochemical pharmacology.

[9]  Shur-Jen Wang,et al.  The Basic Helix-Loop-Helix Transcription Factor HESR1 Regulates Endothelial Cell Tube Formation* , 2001, The Journal of Biological Chemistry.

[10]  L. McIntosh,et al.  Assigning the NMR spectra of aromatic amino acids in proteins: analysis of two Ets pointed domains , 1998 .

[11]  M. DeRuiter,et al.  Ets‐1 and Ets‐2 Transcription Factors Are Essential for Normal Coronary and Myocardial Development in Chicken Embryos , 2003, Circulation research.

[12]  B. Groner,et al.  Activation of Stat5 by interleukin 2 requires a carboxyl-terminal region of the interleukin 2 receptor beta chain but is not essential for the proliferative signal transmission. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[13]  R. Ashmun,et al.  c-Maf induces monocytic differentiation and apoptosis in bipotent myeloid progenitors. , 1999, Blood.

[14]  R. Ashmun,et al.  Separate promoters control transcription of the human aminopeptidase N gene in myeloid and intestinal epithelial cells. , 1991, The Journal of biological chemistry.

[15]  N Muthusamy,et al.  The Ets-1 transcription factor is required for the development of natural killer cells in mice. , 1998, Immunity.

[16]  Runzhao Li,et al.  Regulation of Ets function by protein–protein interactions , 2000, Oncogene.

[17]  A. Bridges,et al.  A synthetic inhibitor of the mitogen-activated protein kinase cascade. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[18]  R. Muise-Helmericks,et al.  Signal transduction and the Ets family of transcription factors , 2000, Oncogene.

[19]  G. Semenza,et al.  Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. , 1999, Annual review of cell and developmental biology.

[20]  S. Srivastava,et al.  Effects of two major activating lesions on the structure and conformation of human ras oncogene products. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[21]  R. Fisher,et al.  High-affinity DNA-protein interactions of the cellular ETS1 protein: the determination of the ETS binding motif. , 1991, Oncogene.

[22]  W. Arap,et al.  CD13/APN is activated by angiogenic signals and is essential for capillary tube formation. , 2001, Blood.

[23]  A. Sharrocks.  The ETS-domain transcription factor family , 2001, Nature Reviews Molecular Cell Biology.

[24]  M. Tymms,et al.  The Ets1 transcription factor is widely expressed during murine embryo development and is associated with mesodermal cells involved in morphogenetic processes such as organ formation. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[25]  W. Schaffner,et al.  Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. , 1989, Nucleic acids research.

[26]  M. Gerritsen,et al.  Peroxisome Proliferator-activated Receptor γ Ligands Are Potent Inhibitors of Angiogenesis in Vitro and in Vivo * , 1999, The Journal of Biological Chemistry.

[27]  Michael C. Ostrowski,et al.  Ras-mediated phosphorylation of a conserved threonine residue enhances the transactivation activities of c-Ets1 and c-Ets2 , 1996, Molecular and cellular biology.

[28]  G. Semenza,et al.  Defective vascularization of HIF-1alpha-null embryos is not associated with VEGF deficiency but with mesenchymal cell death. , 1999, Developmental biology.

[29]  N. Janel,et al.  Ets transcription factors bind and transactivate the core promoter of the  von Willebrand factor gene , 1997, Oncogene.

[30]  D. Hanahan,et al.  Transgenic mouse models of tumour angiogenesis: the angiogenic switch, its molecular controls, and prospects for preclinical therapeutic models. , 1996, European journal of cancer.

[31]  Yasufumi Sato,et al.  Role of ETS family transcription factors in vascular development and angiogenesis. , 2001, Cell structure and function.

[32]  A. Turner,et al.  Endopeptidase‐24.11 and aminopeptidase activity in brain synaptic membranes are jointly responsible for the hydrolysis of cholecystokinin octapeptide (CCK‐8) , 1984, FEBS letters.

[33]  P. Sharp,et al.  RNA interference--2001. , 2001, Genes & development.

[34]  D. Bonthron,et al.  Novel cis-acting elements in the human platelet-derived growth factor B-chain core promoter that mediate gene expression in cultured vascular endothelial cells. , 1994, The Journal of biological chemistry.

[35]  S. Orkin,et al.  Role of SCL/Tal-1, GATA, and ets transcription factor binding sites for the regulation of flk-1 expression during murine vascular development. , 2000, Blood.

[36]  R. Ashmun,et al.  Human myeloid plasma membrane glycoprotein CD13 (gp150) is identical to aminopeptidase N. , 1989, The Journal of clinical investigation.

[37]  Michael C. Ostrowski,et al.  Rapid phosphorylation of Ets-2 accompanies mitogen-activated protein kinase activation and the induction of heparin-binding epidermal growth factor gene expression by oncogenic Raf-1 , 1997, Molecular and cellular biology.

[38]  B. Graves,et al.  An ERK2 docking site in the Pointed domain distinguishes a subset of ETS transcription factors. , 2002, Genes & development.

[39]  B. Vandenbunder,et al.  c-ets1 proto-oncogene is a transcription factor expressed in endothelial cells during tumor vascularization and other forms of angiogenesis in humans. , 1992, The American journal of pathology.

[40]  S. Mckercher,et al.  Defective trophoblast function in mice with a targeted mutation of Ets2. , 1998, Genes & development.

[41]  B. Vandenbunder,et al.  The Ets family contains transcriptional activators and repressors involved in angiogenesis. , 2001, The international journal of biochemistry & cell biology.

[42]  T. Tuschl,et al.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells , 2001, Nature.

[43]  J. C. Fox,et al.  Autocrine Signaling through Ras Prevents Apoptosis in Vascular Smooth Muscle Cells in Vitro * , 2000, The Journal of Biological Chemistry.

[44]  C. Sherr,et al.  Regulation of the CD13/Aminopeptidase N Gene by DMP1, a Transcription Factor Antagonized by D-Type Cyclins* , 1998, The Journal of Biological Chemistry.

[45]  D. Hanahan,et al.  Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis , 1996, Cell.